Generation Bio Co. (GBIO)
USD 1.02
(-6.42%)
USD 1.02
(-6.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -52.74 Million | -102.44 Million | -91.82 Million | -70.14 Million | -40.34 Million | -28.11 Million |
| Net Income | -126.61 Million | -136.63 Million | -119.15 Million | -80.52 Million | -61.31 Million | -35.8 Million |
| Depreciation & Amortization | 5.26 Million | 5.13 Million | 4.53 Million | 3.43 Million | 1.86 Million | 347 Thousand |
| Deferred income taxes | -62.87 Million | - | - | - | -10 Thousand | - |
| Stock-based compensation | 24.34 Million | 24.45 Million | 17.85 Million | 8.41 Million | 4.2 Million | 3.48 Million |
| Change in working capital | 53.53 Million | 1.04 Million | 4.17 Million | -1.71 Million | 15.22 Million | 4.68 Million |
| Other non-cash items | 53.6 Million | 3.56 Million | 766 Thousand | 249 Thousand | -317 Thousand | -834 Thousand |
| Investing Cash Flow | -9.69 Million | -192.51 Million | 193.04 Million | -205.19 Million | 47.98 Million | -69.76 Million |
| Investments in PPE | -7.39 Million | -8.8 Million | -5.95 Million | -5.51 Million | -19.98 Million | -3.02 Million |
| Acquisitions | 2.3 Million | 183.71 Million | 105 Thousand | 199.67 Million | 80 Thousand | - |
| Investment purchases | -405.3 Million | -323.71 Million | -105 Thousand | -243.17 Million | -20.78 Million | -109.94 Million |
| Sales/Maturities of investments | 403 Million | 140 Million | 198.9 Million | 43.5 Million | 88.68 Million | 43.2 Million |
| Other Investing Activities | -2.3 Million | -183.71 Million | 105 Thousand | -199.67 Million | 67.97 Million | -66.74 Million |
| Financing Cash Flow | 35.81 Million | 12.98 Million | 214.67 Million | 323.09 Million | 78 Thousand | 100.18 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -565 Thousand | -581 Thousand | - | - | - | - |
| Common Stock Issuance | 36.38 Million | 12.36 Million | 211.87 Million | 213.9 Million | 100 Thousand | 100.18 Million |
| Other Financing Activities | 36.38 Million | 1.21 Million | 2.79 Million | 109.19 Million | -22 Thousand | 100.18 Million |
| Accounts receivables | -3.56 Million | -395 Thousand | - | 448 Thousand | 840 Thousand | -1.28 Million |
| Accounts payables | 1.08 Million | -1.38 Million | 1.75 Million | -1.44 Million | 761 Thousand | 223 Thousand |
| Inventory | 3.56 Million | 395 Thousand | - | -448 Thousand | -840 Thousand | - |
| Other working capital | 52.45 Million | 2.43 Million | 2.41 Million | -268 Thousand | 14.46 Million | 4.46 Million |
| Cash at beginning of period | 98.86 Million | 380.83 Million | 64.94 Million | 17.18 Million | 9.46 Million | 7.15 Million |
| Cash at end of period | 72.23 Million | 98.86 Million | 380.83 Million | 64.94 Million | 17.18 Million | 9.46 Million |
| Capital Expenditure | -7.39 Million | -8.8 Million | -5.95 Million | -5.51 Million | -19.98 Million | -3.02 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -26.62 Million | -281.97 Million | 315.89 Million | 47.75 Million | 7.71 Million | 2.3 Million |
| Free Cash Flow | -60.14 Million | -111.24 Million | -97.77 Million | -75.66 Million | -60.33 Million | -31.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.43 Million | -74.54 Million | -126.61 Million | -35.18 Million | -28.26 Million | -31.06 Million |
| Depreciation & Amortization | 1.26 Million | 1.31 Million | 5.26 Million | 1.32 Million | 1.29 Million | 1.31 Million |
| Deferred income taxes | - | - | -62.87 Million | -62.87 Million | - | - |
| Stock-based compensation | 3.69 Million | 4 Million | 24.34 Million | 6.04 Million | 6 Million | 6.02 Million |
| Change in working capital | -5.57 Million | -17.06 Million | 53.53 Million | 5.43 Million | -1.42 Million | 50.63 Million |
| Other non-cash items | 6.67 Million | 61.46 Million | 53.6 Million | 60.27 Million | -2.49 Million | -2.09 Million |
| Investing Cash Flow | 12.09 Million | -553 Thousand | -9.69 Million | -1.91 Million | -26.58 Million | 24.41 Million |
| Investments in PPE | -14 Thousand | -1.91 Million | -7.39 Million | -4.58 Million | -610 Thousand | -1.45 Million |
| Acquisitions | 104 Thousand | - | 2.3 Million | -4.96 Million | 25.97 Million | -25.86 Million |
| Investment purchases | - | -86.63 Million | -405.3 Million | -109.33 Million | -128.97 Million | -79.13 Million |
| Sales/Maturities of investments | 12 Million | 88 Million | 403 Million | 112 Million | 103 Million | 105 Million |
| Other Investing Activities | 12.1 Million | 1.36 Million | -2.3 Million | 4.96 Million | -25.97 Million | 25.86 Million |
| Financing Cash Flow | 234 Thousand | -125 Thousand | 35.81 Million | 77 Thousand | -131 Thousand | 99 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -31 Thousand | -125 Thousand | -565 Thousand | -117 Thousand | -131 Thousand | -118 Thousand |
| Common Stock Issuance | 265 Thousand | - | 36.38 Million | 194 Thousand | 1.37 Billion | 217 Thousand |
| Other Financing Activities | -31 Thousand | -125 Thousand | 36.38 Million | 194 Thousand | -131 Thousand | 217 Thousand |
| Accounts receivables | -1.33 Million | - | -3.56 Million | 46.34 Million | -320 Thousand | 1.47 Million |
| Accounts payables | 396 Thousand | -242 Thousand | 1.08 Million | -299 Thousand | -186 Thousand | 756 Thousand |
| Inventory | - | - | 3.56 Million | 1.15 Million | 320 Thousand | -1.47 Million |
| Other working capital | -4.63 Million | -16.82 Million | 52.45 Million | -41.76 Million | -1.24 Million | 49.87 Million |
| Cash at beginning of period | 37.71 Million | 66.44 Million | 98.86 Million | 99.05 Million | 150.66 Million | 101.34 Million |
| Cash at end of period | 28.49 Million | 37.71 Million | 72.23 Million | 72.23 Million | 99.05 Million | 150.66 Million |
| Capital Expenditure | -14 Thousand | -1.91 Million | -7.39 Million | -4.58 Million | -610 Thousand | -1.45 Million |
| Effect of forex changes on cash | - | - | - | -1.79 Billion | 1.43 Billion | 366.31 Million |
| Net cash flow / Change in cash | -9.21 Million | -28.73 Million | -26.62 Million | -26.81 Million | -51.61 Million | 49.32 Million |
| Free Cash Flow | -21.54 Million | -33.61 Million | -60.14 Million | -29.55 Million | -25.5 Million | 23.35 Million |
GPTHEALTH
AGRO3
GWO-PN
LOVABLE
UNITECH
NERV